The Skin Perfusion Pressure Testing Devices Market size is estimated at USD 206.82 million in 2024, and is expected to reach USD 336.59 million by 2029, growing at a CAGR of 10.23% during the forecast period (2024-2029).
Certain factors that are driving the market growth include rising prevalence of peripheral artery disease, increasing prevalence of diabetes, and technological advancements.
Peripheral arterial disease (PAD) is caused by a narrowing or blocking of the blood vessels due to a plaque build-up. This condition can lead to tissue death, heart stroke, aneurysms, or kidney diseases, if left untreated. According to the latest available report published by the National Institute of Health, one in every 20 Americans, who are over the age of 50, has PAD. It has been affecting 8 to 12 million people in the United States, especially those over 50 years. As the population is growing, the prevalence of the disease is also increasing, which could grow from 9.6 million to reach 19 million overall, globally by 2050. With the aging of the global population, it seems likely that PAD will be increasingly common in the future. Hence, the statistics show that the number of PAD is increasing at a faster pace, which is ultimately driving the market of Skin Perfusion Pressure Testing Devices. Other factors, such as the rising prevalence of diabetes and the technological advancements have broadened the range of the Skin Perfusion Pressure Testing Devices.
North American dominates the Skin Perfusion Pressure Testing Devices products market primarily due to the rising incidence of cardiovascular and other chronic diseases, growing geriatric population, and the strong presence of industry players in the region.
According to the International Journal of Epidemiology, 2019, around 610,000 people die due to one or the other heart diseases annually in the United States. Furthermore, approximately 735,000 people in the United States experience heart attack each year.
Asia-Pacific is anticipated to grow tremendously during the forecast period, owing to factors, such as a high prevalence of diabetes, a growing obese population, and government initiatives of raising awareness regarding healthcare. According to IDF, in 2019, USD 324.5 billion was spent on diabetes in the region, which is 42.7% of the total global health expenditure on diabetes.
The global Skin Perfusion Pressure Testing Devices market is competitive and consists of a few major players. Companies like ADInstruments, CorVascular Diagnostics, LLC, Koven Technology, Moor Instruments Limited, Perimed AB, Promed Group, Vasamed, Viasonix, among others, hold the substantial market share in the market.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook